4//SEC Filing
WILSON TROY EDWARD 4
Accession 0001193125-25-223663
CIK 0001422143other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 7:30 PM ET
Size
8.1 KB
Accession
0001193125-25-223663
Insider Transaction Report
Form 4
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-09-29$8.94/sh−36,615$327,419→ 246,853 total - Award
Common Stock
2025-09-27+182,500→ 283,468 total
Holdings
- 279,194(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001589597
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 7:30 PM ET
- Size
- 8.1 KB